Ovoca Bio is a clinical-stage biopharmaceutical company with a focus on women’s health. The Company is currently developing a novel treatment for women with hypoactive sexual desire disorder (HSDD), a condition characterized by a distressing lack or loss of sexual desire. The Society for Women’s Health Research estimates that about one in ten premenopausal women suffer from HSDD, making it one of the most common female sexual problems. Founded and incorporated in Ireland, Ovoca Bio currently operates in Ireland, the UK, and Russia, and is listed on AIM and Euronext Growth in London and Dublin.
View Top Employees from Ovoca Bio plcWebsite | https://ovocabio.com/ |
Revenue | $5 million |
Employees | 3 (2 on RocketReach) |
Address | 17 Pembroke Street Upper, Dublin, County Dublin 2, IE |
Phone | +353 1 661 9819 |
Fax | +353 1 661 9895 |
Technologies |
JavaScript,
HTML,
PHP
+7 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Ovoca Bio plc employee's phone or email?
The Ovoca Bio plc annual revenue was $5 million in 2024.
Dmitriy Nikitashenko is the Vice President Finance of Ovoca Bio plc.
2 people are employed at Ovoca Bio plc.
Ovoca Bio plc is based in Dublin, County Dublin.
The NAICS codes for Ovoca Bio plc are [32, 3254, 325].
The SIC codes for Ovoca Bio plc are [28, 80, 283].